Literature DB >> 2148327

Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder.

T B Pearlstein1, E Frank, A Rivera-Tovar, J S Thoft, E Jacobs, T A Mieczkowski.   

Abstract

The authors interviewed 78 female patients with late luteal phase dysphoric disorder and found a 78% lifetime prevalence of axis I disorders but only a 10% prevalence of axis II disorders. A prior depression was the predominant axis I disorder found, and 29% of parous patients had a prior postpartum depression. A comparison of Global Assessment Scale scores obtained at both the follicular and luteal phases of the menstrual cycle confirmed luteal increases in symptoms and role impairment.

Entities:  

Mesh:

Year:  1990        PMID: 2148327     DOI: 10.1016/0165-0327(90)90126-s

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  24 in total

1.  Persistent alterations in biological profiles in women with abuse histories: influence of premenstrual dysphoric disorder.

Authors:  Susan S Girdler; Jane Leserman; Robertas Bunevicius; Rebecca Klatzkin; Cort A Pedersen; Kathleen C Light
Journal:  Health Psychol       Date:  2007-03       Impact factor: 4.267

Review 2.  Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?

Authors:  Shannon K Crowley; Susan S Girdler
Journal:  Psychopharmacology (Berl)       Date:  2014-04-23       Impact factor: 4.530

3.  Personal history of major depression may put women at risk for premenstrual dysphoric symptomatology.

Authors:  Eynav E Accortt; Anya V Kogan; John J B Allen
Journal:  J Affect Disord       Date:  2013-06-22       Impact factor: 4.839

Review 4.  Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.

Authors:  M Steiner
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

Review 5.  Role of estrogen in the aetiology and treatment of mood disorders.

Authors:  U Halbreich; L S Kahn
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 6.  Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents.

Authors:  Andrea J Rapkin; Judith A Mikacich
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

7.  Menstrual mood disorders are associated with blunted sympathetic reactivity to stress.

Authors:  Rebecca R Klatzkin; Adomas Bunevicius; Catherine A Forneris; Susan Girdler
Journal:  J Psychosom Res       Date:  2013-11-12       Impact factor: 3.006

8.  The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study.

Authors:  K R Merikangas; M Foeldenyi; J Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

Review 9.  The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders.

Authors:  Andrea J Rapkin; Judith A Mikacich; Babak Moatakef-Imani; Natalie Rasgon
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

Review 10.  Neurosteroids in the context of stress: implications for depressive disorders.

Authors:  Susan S Girdler; Rebecca Klatzkin
Journal:  Pharmacol Ther       Date:  2007-05-24       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.